Search clinical trials for: Sarcosine

Total 102 results

Chang-Hua Hospital
China Medical University Hospital

Completed

Treatment of N-methyl-D-aspartate (NMDA) Enhancers for Schizophrenia

Schizophrenia

Taiwan
China Medical University Hospital
National Science Council, Taiwan; National Health Research Institutes, Taiwan

Completed

Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia

Psychotic Disorders | Schizophrenic Disorders | Schizophrenias | Psychoses

Taiwan
Herzog Hospital

Withdrawn

Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia

Psychotic Disorders | Schizophrenic Disorders | Schizophrenias | Psychoses

Israel
Monash University
Monash Health

Recruiting

Carnosine for Peripheral Vascular Disease (Car-PVD)

Peripheral Arterial Disease

Australia
Monash University

Recruiting

The Potential of Carnosine Supplementation in Optimising Cardiometabolic Health

Cardiovascular Risk Factors | Cognitive Function 1, Social | Poor Glycemic Control

Australia
University of Pittsburgh
National Alliance for Research on Schizophrenia and Depression

Completed

L-Carnosine for Bipolar I Disorder

Bipolar I Disorder

United States
University of Louisville

Recruiting

Carnosine for Peripheral Arterial Disease Patients (CAR-PAD)

Peripheral Arterial Disease

United States
Jozef Ukropec

Completed

Effect of Carnosine on Diabetes and Cardiovascular Risk Factors (Carnorisk)

Metabolic Diseases, Type 2 Diabetes, Cardiovascular Disease

Slovakia
Cairo University
Ain Shams University; Misr International University

Completed

L-carnosine Prophylactic Effect on Oxaliplatin Induced Peripheral Neuropathy in GIT Cancer Patients

Cancer | Peripheral Neuropathy

Egypt
China Medical University Hospital
National Science Council, Taiwan

Completed

The Impact of Pharmacological and Electric Modulation of NMDA Pathway on the Cognitive Flexibility and Volitional Movement Preparation in Patients With Parkinson's Disease

Parkinson's Disease With Dementia

Taiwan
University of Pittsburgh
Stanley Medical Research Institute

Completed

L-carnosine for Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Abraham Reichenberg
Stanley Medical Research Institute

Completed

Carnosine and Cognitive Training in Schizophrenia (CACTIS)

Schizophrenia

United States
Ain Shams University

Completed

Role of Carnosine as an Adjuvant Therapy for Diabetic Nephropathy in Pediatrics With Type 1 Diabetes

Type 1 Diabetes | Diabetic Nephropathy | Oxidative Stress | Carnosine
Josip Juraj Strossmayer University of Osijek

Recruiting

Carnosine Supplementation and Cardiovascular Function

Carnosine

Croatia
China Medical University Hospital
National Science Council, Taiwan; National Health Research Institutes, Taiwan

Completed

Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia

Psychotic Disorders | Schizophrenic Disorders | Schizophrenias | Psychoses

Taiwan
University of Louisville
National Institute of Environmental Health Sciences (NIEHS)

Completed

Nucleophilic Defense Against PM Toxicity (NEAT Trial) (NEAT)

Air Pollution Toxicity

United States
University of Louisville

Completed

Carnosine for Peripheral Arterial Disease ((Car-PAD))

Peripheral Arterial Disease

United States
Slovak Academy of Sciences
National Cheng Kung University; Comenius University; University Hospital Bratislava

Unknown

Molecular Mediators of Physical Exercise and Carnosine Induced Effects in Patients With Preclinical and Early Stage Neurodegenerative Disease

Parkinson Disease | Healthy Volunteers | Mild Cognitive Impairment | Subjective Cognitive Impairment

Slovakia, Taiwan
Georgetown University

Completed

Treatment Study of Carnosine Versus Placebo in Gulf War Illness (GWI)

Persian Gulf Syndrome

United States
Beni-Suef University

Completed

Role of Carnosine in Combination With Vitamin B Complex in Preventing the Progression of Diabetic Neuropathy in Type 2 Diabetes Patients

Diabetic Neuropathies

Egypt
Monash University

Unknown

The Potential of Carnosine Supplementation in Reducing the Cardiometabolic Risk

Insulin Sensitivity

Australia
University of Novi Sad, Faculty of Sport and Physical...
CarnoMed

Completed

Oral Carnosine for Neuromuscular Performance in Multiple Sclerosis (CARMUS)

Multiple Sclerosis

Serbia
Slovak Academy of Sciences
Medical University of Vienna

Recruiting

Research on Prevention, Intervention and Mechanisms of Obesity and Its Comorbidities (Obesity)

Obesity | Exercise | Nutrition, Healthy

Slovakia
Massachusetts General Hospital
National Institute on Drug Abuse (NIDA)

Completed

A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia (Sarc)

Schizophrenia

United States
China Medical University Hospital
Taipei City Hospital

Completed

N-methyl Glycine (Sarcosine) for the Treatment of Obsessive Compulsive Disorder (OCD)

Obsessive Compulsive Disorder

Taiwan
Medical University of Lodz

Completed

Effect of Sarcosine on Symptomatology, Quality of Life, Oxidative Stress and Glutamatergic Parameters in Schizophrenia (PULSAR)

Schizophrenia

Poland
Tufts University

Completed

Pharmacokinetics of Carnosine

Oxidative Stress

United States
University of Michigan
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Carbon-11 Labeled Sarcosine in Prostate Cancer

Prostate Cancer

United States
IRCCS Policlinico S. Matteo

Unknown

Efficacy of Zinc L-carnosine in Maintaining Remission of Gastroesophageal Reflux Disease (GERDILOR)

Gastroesophageal Reflux Disease

Italy
All India Institute of Medical Sciences, Bhubaneswar

Completed

Evaluation of Efficacy and Safety of add-on Sarcosine in Patients With Major Depressive Disorder

Major Depressive Disorder

India
China Medical University Hospital
National Science Council, Taiwan

Completed

N-methylglycine (Sarcosine) Treatment for Depression

Depression | Major Depression | Major Depressive Disorder

Taiwan
University of Milan
Azienda Farmaceutica Italiana s.r.l.

Unknown

Efficacy of Zinc L-Carnosine Mouth Rinse

Pain | Periodontal Index

Italy
Kanazawa University
Kowa Company, Ltd.

Completed

SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD

Non-alcoholic Fatty Liver Disease

Japan
Fundació Eurecat
Centre de Diagnosi per la Imatge; Laboratorio de Referencia Sud; Centro OWLiver

Completed

Effect of a Multi-ingredient on Visceral Adiposity and Non-alcoholic Fatty Liver Disease in Individuals With Abdominal Obesity (FATHIS)

Non-Alcoholic Fatty Liver Disease | Visceral Obesity

Spain
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Intra-arterial Melphalan in Treating Younger Patients With Unilateral Retinoblastoma

Unilateral Retinoblastoma

United States
Fuling Central Hospital of Chongqing City

Completed

The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment (CONTRAST-CADT)

Coronary Disease | Hypertension | Nephropathy | Contrast Media | Homocysteine | Angioplasty,Balloon,Coronary

China
Imperial College London
Wexham GI Trust

Completed

Effect of Zinc Carnosine on Intestinal Permeability in Healthy Volunteers

Healthy

United Kingdom
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Minimal Residual Disease | Hematopoietic Cell Transplantation Recipient | Acute Myeloid Leukemia in Remission | Acute Lymphoblastic Leukemia in Remission

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma

Plasma Cell Myeloma | Secondary Amyloidosis

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma

Refractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma

United States
Roswell Park Cancer Institute

Active, not recruiting

Genetically Engineered Cells (NY-ESO-1 TCR Engineered T Cells and HSCs) After Melphalan Conditioning Regimen in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Platinum-Sensitive Ovarian Carcinoma | Refractory Ovarian... and other conditions

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation

Primary Myelofibrosis | Acute Leukemia | Myelodysplastic Syndrome | Secondary Myelofibrosis | Hematologic and Lymphocytic Disorder

United States
Assiut University

Unknown

Steroid Therapy in Acute Bronchiolitis A New Old Line of Therapy.

Bronchiolitis; Respiratory Syncytial Virus
National Cancer Institute (NCI)

Withdrawn

RO4929097 After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

Refractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple Myeloma

Plasma Cell Myeloma | Plasma Cell Leukemia

United States
National Cancer Institute (NCI)

Active, not recruiting

Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Smoldering Multiple Myeloma | Refractory Multiple Myeloma | DS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple Myeloma

United States
OHSU Knight Cancer Institute
National Institute of Neurological Disorders and Stroke (NINDS); Oregon Health...

Active, not recruiting

Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors

Medulloblastoma | Recurrent Malignant Germ Cell Tumor | Recurrent Medulloblastoma | Germ Cell Tumor | Primitive Neuroectodermal Tumor | Medulloepithelioma | Recurrent Primitive Neuroectodermal Tumor | Embryonal Tumor With Multilayered Rosettes, C19MC-Altered | Recurrent Childhood Central Nervous System... and other conditions

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Withdrawn

Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma

Plasma Cell Myeloma

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Withdrawn

Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis

Primary Myelofibrosis | Secondary Acute Myeloid Leukemia | Secondary Myelofibrosis | Acute Myeloid Leukemia in Remission | Primary Myelofibrosis, Prefibrotic Stage

United States
Children's Oncology Group

Recruiting

A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

Bilateral Retinoblastoma | Childhood Intraocular Retinoblastoma | Unilateral Retinoblastoma | Group D Retinoblastoma | Stage I Retinoblastoma

United States

Search clinical trials for: Sarcosine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations